My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 268

    1.

    Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial.

    Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D.

    Diabetes Care. 2003 Jan;26(1):138-43.PMID: 12502670 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    3.

    The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.

    Freemark M, Bursey D.

    Pediatrics. 2001 Apr;107(4):E55.PMID: 11335776 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Roberts VL, Stewart J, Issa M, Lake B, Melis R.

    Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

    5.

    Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

    Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.

    Diabetes Care. 2006 Mar;29(3):554-9.PMID: 16505505 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity.

    Särnblad S, Kroon M, Aman J.

    Eur J Endocrinol. 2003 Oct;149(4):323-9.PMID: 14514347 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The addition of rosiglitazone to insulin in adolescents with type 1 diabetes and poor glycaemic control: a randomized-controlled trial.

    Stone ML, Walker JL, Chisholm D, Craig ME, Donaghue KC, Crock P, Anderson D, Verge CF.

    Pediatr Diabetes. 2008 Jul 28;9(4 Pt 1):326-34. Epub 2008 May 7.PMID: 18466213 [PubMed - indexed for MEDLINE]Related articles

    9.

    Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.

    Goldstein BJ, Pans M, Rubin CJ.

    Clin Ther. 2003 Mar;25(3):890-903.PMID: 12852706 [PubMed - indexed for MEDLINE]Related articles

    10.

    Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

    Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

    Diabetes Care. 1998 Apr;21(4):574-9.PMID: 9571345 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus.

    Alemzadeh R, Berhe T, Wyatt DT.

    Pediatrics. 2005 May;115(5):1320-4.PMID: 15867042 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

    Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

    Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

    13.

    Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents.

    Abdelghaffar S, Attia AM.

    Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006691. Review.PMID: 19160294 [PubMed - indexed for MEDLINE]Related articles

    14.

    Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

    Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

    Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of two different glibenclamide dose-strengths in the fixed combination with metformin in patients with poorly controlled T2DM: a double blind, prospective, randomised, cross-over clinical trial.

    Brunetti P, Pagano G, Turco C, Gori M, Perriello G; Glibo 5 Study Group.

    Diabetes Nutr Metab. 2004 Dec;17(6):350-7.PMID: 15887629 [PubMed - indexed for MEDLINE]Related articles

    16.

    Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study.

    Bailey CJ, Bagdonas A, Rubes J, McMorn SO, Donaldson J, Biswas N, Stewart MW.

    Clin Ther. 2005 Oct;27(10):1548-61.PMID: 16330291 [PubMed - indexed for MEDLINE]Related articles

    17.

    Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.

    Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D.

    Clin Ther. 2000 Jun;22(6):709-18.PMID: 10929918 [PubMed - indexed for MEDLINE]Related articles

    18.

    Starting insulin in type 2 diabetes: continue oral hypoglycemic agents? A randomized trial in primary care.

    Goudswaard AN, Stolk RP, Zuithoff P, de Valk HW, Rutten GE.

    J Fam Pract. 2004 May;53(5):393-9.PMID: 15125825 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

    Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL.

    Am J Med. 1997 Dec;103(6):491-7.PMID: 9428832 [PubMed - indexed for MEDLINE]Related articles

    20.

    Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial.

    Douek IF, Allen SE, Ewings P, Gale EA, Bingley PJ; Metformin Trial Group.

    Diabet Med. 2005 May;22(5):634-40.PMID: 15842521 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity